Disease Diagnosis

TTR Sequencing

Overview

Test Name

TTR Sequencing

Test Code

SG1006

Test Category

Single Gene Tests

Test Subcategory

Disease Diagnosis

Disease(s) Targeted

Transthyretin Amyloiodsis (ATTR)

Who Is The Test For?

Patients who are suspected to have Transthretin Amyloidosis (ATTR) a rare hereditary progressive disease.

Variants

All exonic regions in the TTR gene.

Deliverables

Clinical Report (Download a sample report here)

Turnaround Time

2 weeks

Specimen Requirements

For detailed information about the sample requirements, please consult our clinical sample requirements page.

A minimum of 3ml of blood is required per sample for testing.

*Turnaround times are estimated from receipt of satisfactory specimen and test request form at the laboratory to release of clinical report. The turnaround time may vary depending on the nature of the specimen and the complexity of the investigation required. The above table is only a guideline and the complexity of a case and the requirement for further investigations may change this.

About Transthyretin Amyloiodsis (ATTR)

Transthyretin Amyloidosis (ATTR), is a rare progressive disease caused by misfolded Transthyretin (TTR) protein deposits in tissues. Hereditary ATTR (hATTR) is inherited in an autosomal dominant manner, with symptoms typically starting in adulthood. Variants in the TTR gene cause amyloid build up, leading to tissue damage.